Veracyte Financial Statements From 2010 to 2025

Stocks USA . 
Stock . Veracyte
VCYT Stock  USD 33.46  5.90  14.99%   
Veracyte financial statements provide useful quarterly and yearly information to potential Veracyte investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Veracyte financial statements helps investors assess Veracyte's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Veracyte's valuation are summarized below:
Gross Profit
309.7 M
Profit Margin
0.0542
Market Capitalization
2.6 B
Enterprise Value Revenue
6.5828
Revenue
445.8 M
There are currently one hundred twenty fundamental trend indicators for Veracyte that can be evaluated and compared over time across competition. All traders should double-check Veracyte's current fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.9 B in 2025. Enterprise Value is likely to gain to about 1.7 B in 2025

Veracyte Total Revenue

435.97 Million

Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.8 M, Interest Expense of 16.4 K or Selling General Administrative of 190.3 M, as well as many indicators such as Price To Sales Ratio of 6.05, Dividend Yield of 0.0 or PTB Ratio of 2.09. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
  
Check out the analysis of Veracyte Correlation against competitors.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Veracyte Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.3 B1.3 B461.2 M
Slightly volatile
Other Current Liabilities49.7 M47.4 M19.2 M
Slightly volatile
Total Current Liabilities73.9 M70.4 M29 M
Slightly volatile
Total Stockholder Equity1.3 B1.2 B417.8 M
Slightly volatile
Other Liabilities5.6 M8.7 M5.2 M
Slightly volatile
Property Plant And Equipment Net37.3 M35.5 M15.8 M
Slightly volatile
Accounts Payable15.6 M14.9 M6.4 M
Slightly volatile
Cash261.4 M248.9 M119.3 M
Slightly volatile
Non Current Assets Total1 B953.7 M308.8 M
Slightly volatile
Other Assets1.091.151.6 M
Slightly volatile
Cash And Short Term Investments261.4 M248.9 M120.8 M
Slightly volatile
Net Receivables48.8 M46.4 M18.9 M
Slightly volatile
Common Stock Total Equity86.9 K82.8 K42.3 K
Slightly volatile
Common Stock Shares Outstanding87.7 M83.5 M42.3 M
Slightly volatile
Liabilities And Stockholders Equity1.3 B1.3 B461.2 M
Slightly volatile
Non Current Liabilities Total17.6 M11 M14.8 M
Slightly volatile
Inventory19.5 M18.5 M7.2 M
Slightly volatile
Other Current Assets15.3 M14.6 M5.6 M
Slightly volatile
Total Liabilities44.5 M81.4 M40.8 M
Slightly volatile
Property Plant And Equipment Gross76.9 M73.3 M22.3 M
Slightly volatile
Total Current Assets344.9 M328.5 M152.5 M
Slightly volatile
Common Stock42.9 K84 K39.7 K
Slightly volatile
Property Plant Equipment37.3 M35.5 M14.8 M
Slightly volatile
Short and Long Term Debt Total16.8 M14.5 M13.4 M
Slightly volatile
Net Tangible Assets458 M436.2 M175.3 M
Slightly volatile
Long Term Debt884.9 K931.5 K6.9 M
Pretty Stable
Long Term Debt Total884.9 K931.5 K6.9 M
Pretty Stable
Capital Surpluse1.8 B1.7 B682.6 M
Slightly volatile
Deferred Long Term Liabilities4.3 M5.2 M4.1 M
Slightly volatile
Short and Long Term Debt963.6 K1 M5.6 M
Slightly volatile
Short Term Debt7.1 M4.6 M7.5 M
Very volatile
Net Invested Capital1.3 B1.2 B365.4 M
Slightly volatile
Net Working Capital195.5 M258 M124.4 M
Slightly volatile
Capital Stock66.9 K84 K52.7 K
Slightly volatile
Non Current Liabilities Other1.1 M1.2 M13.7 M
Slightly volatile
Current Deferred Revenue2.7 M2.3 M1.1 M
Slightly volatile

Veracyte Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization32.8 M31.3 M10.7 M
Slightly volatile
Selling General Administrative190.3 M181.3 M57.2 M
Slightly volatile
Selling And Marketing Expenses40.9 M30.6 M34.8 M
Slightly volatile
Total Revenue436 M415.2 M145.1 M
Slightly volatile
Other Operating Expenses539.6 M513.9 M187.2 M
Slightly volatile
Research Development69.2 M65.9 M24.3 M
Slightly volatile
Cost Of Revenue136.3 M129.8 M49 M
Slightly volatile
Total Operating Expenses403.2 M384 M138.2 M
Slightly volatile
Interest Income6.8 M6.5 M2.1 M
Slightly volatile
Reconciled Depreciation33.1 M31.5 M11.5 M
Slightly volatile

Veracyte Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation40 M38.1 M13.4 M
Slightly volatile
Begin Period Cash Flow99.9 M178.2 M91.4 M
Slightly volatile
Depreciation32.8 M31.3 M10.4 M
Slightly volatile
Capital Expenditures12 M11.5 M4.5 M
Slightly volatile
End Period Cash Flow262.4 M249.9 M119.7 M
Slightly volatile
Change To Netincome33.3 M31.8 M12.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.056.3715.7045
Slightly volatile
PTB Ratio2.092.28.1049
Slightly volatile
Days Sales Outstanding35.0336.7442.0397
Slightly volatile
Book Value Per Share13.5812.946.8437
Slightly volatile
Stock Based Compensation To Revenue0.110.09180.1121
Slightly volatile
Capex To Depreciation0.40.420.8573
Slightly volatile
PB Ratio2.092.28.1049
Slightly volatile
Inventory Turnover5.556.37.0313
Slightly volatile
Days Of Inventory On Hand61.6759.9655.3237
Pretty Stable
Payables Turnover6.247.857.5518
Slightly volatile
Sales General And Administrative To Revenue0.580.50.6239
Slightly volatile
Research And Ddevelopement To Revenue0.170.180.5083
Slightly volatile
Capex To Revenue0.05970.03170.0564
Slightly volatile
Cash Per Share3.813.433.3004
Very volatile
Days Payables Outstanding73.6248.1266.2773
Slightly volatile
Intangibles To Total Assets0.670.640.3045
Slightly volatile
Net Debt To EBITDA4.273.714.8698
Slightly volatile
Current Ratio4.984.25.9194
Pretty Stable
Tangible Book Value Per Share2.493.132.9176
Very volatile
Receivables Turnover11.1210.2810.2736
Slightly volatile
Graham Number9.3416.3811.3203
Pretty Stable
Shareholders Equity Per Share13.5812.946.8437
Slightly volatile
Debt To Equity0.01320.01390.134
Pretty Stable
Capex Per Share0.120.160.1107
Very volatile
Graham Net Net1.962.282.2847
Very volatile
Revenue Per Share4.74.472.7078
Slightly volatile
Interest Debt Per Share0.190.20.5999
Slightly volatile
Debt To Assets0.01240.0130.0821
Pretty Stable
Operating Cycle79.8883.6695.4972
Slightly volatile
Price Book Value Ratio2.092.28.1049
Slightly volatile
Days Of Payables Outstanding73.6248.1266.2773
Slightly volatile
Ebt Per Ebit1.11.031.0012
Very volatile
Company Equity Multiplier1.731.231.5332
Slightly volatile
Long Term Debt To Capitalization0.00210.00220.091
Slightly volatile
Total Debt To Capitalization0.01310.01370.1007
Slightly volatile
Debt Equity Ratio0.01320.01390.134
Pretty Stable
Quick Ratio4.983.965.8852
Pretty Stable
Net Income Per E B T1.161.121.2055
Slightly volatile
Cash Ratio4.153.184.9248
Pretty Stable
Days Of Inventory Outstanding61.6759.9655.3237
Pretty Stable
Days Of Sales Outstanding35.0336.7442.0397
Slightly volatile
Price To Book Ratio2.092.28.1049
Slightly volatile
Fixed Asset Turnover5.7410.536.9412
Slightly volatile
Debt Ratio0.01240.0130.0821
Pretty Stable
Price Sales Ratio6.056.3715.7045
Slightly volatile
Asset Turnover0.520.370.4568
Pretty Stable
Price Fair Value2.092.28.1049
Slightly volatile

Veracyte Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.9 B1.8 B1 B
Slightly volatile
Enterprise Value1.7 B1.6 B911.2 M
Slightly volatile

Veracyte Fundamental Market Drivers

Forward Price Earnings41.6667
Cash And Short Term Investments216.5 M

Veracyte Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.3 M2.7 M
Total Revenue415.2 M436 M
Cost Of Revenue129.8 M136.3 M
Stock Based Compensation To Revenue 0.09  0.11 
Sales General And Administrative To Revenue 0.50  0.58 
Research And Ddevelopement To Revenue 0.18  0.17 
Capex To Revenue 0.03  0.06 
Revenue Per Share 4.47  4.70 
Ebit Per Revenue(0.21)(0.22)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY